Dementia Prevention: What Advice Should We Give To Baby Boomers And Generation X? | 12448
Journal of Alzheimers Disease & Parkinsonism
Like us on:
Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.
The prevalence of Alzheimer?s Disease and other dementias is growing rapidly, with estimates of a crippling
number of affected persons by the year 2030 as the Baby Boomers and Generation X members reach high
dementia probability ages. Current medical interventions to treat dementing disorders have been disappointing
and suggest that amyloid clearing agents are likely not the answer. More concerning is the absence of highly
promising treatments on the horizon. As a result, prevention becomes an increasingly important strategy for
society as well as a response to a critical question presented by the children of current dementia patients: ?What
can I do to avoid this happening to me??
This presentation will focus on currently available medical, lifestyle, and behavioral strategies that, in a
combined fashion, are the best advice for these aging middle ages. The presentation will provide a framework for
translating a sometimes confusing array of study outcomes into language that is understandable and usable by this
generation. We will specifically examine the roles of elevated lipids, homocysteine and Hemoglobin A1C, as well
as dietary choices, exercise, sleep disordered breathing, mental stimulation, and other factors that together may
make a significant difference in ultimate mental outcome. Since some of these interventions require significant
behavior change, we will also address the issue of psychological resistance and adherence maximization.
Mitchell Clionsky, Ph.D. ABPP-CN is a Board Certified Clinical Neuropsychologist with 35 years of experience in assessing and treating
patients with neurological conditions. He and his clinical staff perform 600 dementia evaluations per year. He is the co-developer of
the Memory Orientation Screening Test, a well-validated brief measure of cognition and dementia identification that is now available on
three iPad apps. He is the co-Editor-in-Chief of the Journal of Alzheimer?s Disease and Parkinsonism.
Peer Reviewed Journals
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals